Inactief instrument

Andere talen Alopexx, Inc.

Aandelen

Alopexx, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	14/03
Alopexx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	27/12
Alopexx to Present Data on F598, a Novel, Broad-Spectrum Immunotherapeutic at IDWeek 2023	12-10-23
Alopexx, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	18-11-22
Alopexx, Inc. has filed an IPO in the amount of $18.328125 million.	04-03-22

Geen resultaten voor deze zoekopdracht